These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24578646)
21. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting. Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537 [TBL] [Abstract][Full Text] [Related]
22. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity. Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466 [TBL] [Abstract][Full Text] [Related]
23. K237-modified thermosensitive liposome enhanced the delivery efficiency and cytotoxicity of paclitaxel in vitro. Fu X; Lu Y; Guo J; Liu H; Deng A; Kuang C; Xie X J Liposome Res; 2019 Mar; 29(1):86-93. PubMed ID: 29671386 [TBL] [Abstract][Full Text] [Related]
24. Dual-targeting liposomes with active recognition of GLUT Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933 [TBL] [Abstract][Full Text] [Related]
25. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation. Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968 [TBL] [Abstract][Full Text] [Related]
26. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
27. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
28. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity. Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603 [TBL] [Abstract][Full Text] [Related]
29. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. Danhier F; Vroman B; Lecouturier N; Crokart N; Pourcelle V; Freichels H; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Dec; 140(2):166-73. PubMed ID: 19699245 [TBL] [Abstract][Full Text] [Related]
30. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide. Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655 [TBL] [Abstract][Full Text] [Related]
31. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726 [TBL] [Abstract][Full Text] [Related]
32. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation. Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350 [TBL] [Abstract][Full Text] [Related]
33. Liposomes actively recognizing the glucose transporter GLUT Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116 [TBL] [Abstract][Full Text] [Related]
34. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
35. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
36. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related]
37. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma. Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068 [TBL] [Abstract][Full Text] [Related]
38. Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes. Guo B; Xu D; Liu X; Yi J Drug Des Devel Ther; 2017; 11():1839-1847. PubMed ID: 28684902 [TBL] [Abstract][Full Text] [Related]
39. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480 [TBL] [Abstract][Full Text] [Related]
40. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]